Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 1

Status

Completed 56Unknown 16Recruiting 10Terminated 8Withdrawn 6Active not recruiting 4Not yet recruiting 3

Sponsor Class

OTHER 3NETWORK 1INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 1

Conditions

Opioid-Related Disorders 1Neuroma 1Neoplasms 1Cancer Pain 1Breast Neoplasms 1

Interventions

Drug Therapy 107Cisplatin 97Radiotherapy 89Carboplatin 87Bevacizumab 79Oxaliplatin 74tislelizumab 68Capecitabine 68Gemcitabine 64Cyclophosphamide 64toripalimab 62Paclitaxel 57pembrolizumab 55sintilimab 53Specimen Handling 53Surgical Procedures, Operative 52anlotinib 49Fluorouracil 49Magnetic Resonance Spectroscopy 48Immune Checkpoint Inhibitors 43Blood Specimen Collection 42130-nm albumin-bound paclitaxel 42Standard of Care 38camrelizumab 36fludarabine 35lenvatinib 34Leucovorin 34venetoclax 30Radiosurgery 30Immunotherapy 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × OTHER × Lidocaine × Clear all
NCT07624890 2026-06-03

PRP-NEUROMA

Ukrainian Society of Regional Anesthesia and Pain Therapy

Phase NA Not yet recruiting
100 enrolled

Neuroma

NCT07408193 2026-02-20

The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.

National and Kapodistrian University of Athens

Phase EARLY_PHASE1 Not yet recruiting
24 enrolled

Cancer Pain, Opioid-Related Disorders, Neoplasms

NCT07108959 2025-08-07

ESPB

Alexandria University

Phase NA Not yet recruiting
40 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡